PROM1 and cancer: CXCL9 binding to CXCR3 activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling, with consequent increased MMP2 and MMP9 expression that, in turn, promoted the invasion and metastasis activity of the CD133+ cancer stem cells [37].